NIFTY 50 23165.35 ▼ (0.77%)
NIFTY NEXT 50 63924.5 ▼ (1.81%)
NIFTY 100 23817.25 ▼ (0.96%)
NIFTY MIDCAP 100 54193.05 ▼ (1.66%)
NIFTY SMALLCAP 100 17570.85 ▼ (1.64%)
NIFTY SMALLCAP 250 16580.1 ▼ (1.55%)
NIFTY MIDCAP SELECT 12101.6 ▼ (2.06%)
NIFTY TOTAL MARKET 12167.55 ▼ (1.11%)
NIFTY BANK 48704.6 ▼ (1.31%)
SENSEX 76326.87 ▼ (0.97%)
BSE BANKEX 55243.59 ▼ (1.41%)

Bayer CropScience : Q4 2024 Financial Quarterly Report : YoY Sales Down 19.44 %, QoQ Down 17.11 %

May 24, 2024May 24, 2024| adminadmin| 0 Comments| 6:45 pm
Image is loading
Categories:

Share the post "Bayer CropScience : Q4 2024 Financial Quarterly Report : YoY Sales Down 19.44 %, QoQ Down 17.11 %"

  • Facebook
  • LinkedIn
  • X
  • Tumblr
  • WhatsApp
  • TelegramTelegram
  • Email

Highlights

  • Sales over the Year and quarter: The company’s sales declined by -19.44 % over the year, decrease in net sales/revenue by -17.11 %.
  • Income over the Year and quarter: There has been either a marginal increase or a decline in other income over the past year which is 43 %. Marginal increase in other income during this quarter, up by 102.74%.
  • Profit over the Year and quarter: Challenges in sustaining profitability for Bayer CropScience Limited.. Profit dropped by -39.43 % Year to Year, Bayer CropScience Limited.’s profitability increased by 3.11 % in this quarter.
  • EPS over the Year and quarter: EPS declined by -39.44 % Year to Year. EPS increased by 3.09 % in previous quarter. Positive impact on shareholders.

The comprehensive analytics outlining the performance and outlook of Bayer CropScience Limited.”s stock. This analysis encompasses various metrics including stock performance, investor sentiment, market trends, future outlook, risk factors, investment opportunities, long-term strategy, dividend policy, analyst insights, and the overall risk-reward profile. These insights aim to provide investors with a holistic understanding of the company”s stock, enabling informed decision-making and strategic investment planning.

Metrics Previous Year Previous Quarter Current Quarter Quarter to Quarter Difference Year to Year Difference
Sales Rs. 982.5 Cr Rs. 954.9 Cr Rs. 791.5 Cr -17.11 % -19.44 %
Expenses Rs. 776.7 Cr Rs. 827 Cr Rs. 694.9 Cr -15.97 % -10.53 %
Operating Profit Rs. 205.8 Cr Rs. 127.9 Cr Rs. 96.6 Cr -24.47 % -53.06 %
OPM % 20.95 % 13.39 % 12.2 % -1.19 % -8.75 %
Other Income Rs. 20.7 Cr Rs. 14.6 Cr Rs. 29.6 Cr + 102.74 % + 43 %
Interest Rs. 7.3 Cr Rs. 3.1 Cr Rs. 4.9 Cr + 58.06 % -32.88 %
Depreciation Rs. 27.1 Cr Rs. 15.2 Cr Rs. 15.9 Cr + 4.61 % -41.33 %
Profit before tax Rs. 192.1 Cr Rs. 124.2 Cr Rs. 105.4 Cr -15.14 % -45.13 %
Tax % 18.8 % 25.04 % 8.92 % -16.12 % -9.88 %
Net Profit Rs. 158.5 Cr Rs. 93.1 Cr Rs. 96 Cr + 3.11 % -39.43 %
EPS in Rs Rs. 35.27 Rs. 20.72 Rs. 21.36 + 3.09 % -39.44 %


Today, we’re looking at Bayer CropScience Limited.’s financial performance for the Q4(Mar 2024).Starting with the top line, the company reported a significant year-over-year sales decline of -19.44 %. However, it did see a marginal slip of -17.11 % from the previous quarter. Expenses decreased slightly by -15.97 % quarter-on-quarter, aligning with the annual decline of -10.53 %. Operating profit, while down -53.06 % compared to last year, faced a quarter-on-quarter dip of -24.47 %, signaling a short-term contraction in margins.
The Operating Profit Margin (OPM) % contradicts this narrative, showing weakness on an annual basis with a decrease of -8.75 %, but a shrinkage of -1.19 % sequentially. Other income rose by 102.74 % compared to the last quarter, despite an annual growth of 43 %. Interest expenses surged remarkably by 58.06 % from the previous quarter, yet the year-over-year decrease remains at a moderate -32.88 %. Depreciation costs climbed by 4.61 % quarter-on-quarter, yet on an annual scale, they experienced a reduction of -41.33 %. Profit before tax declined annually by -45.13 % but saw a reduction from the preceding quarter by -15.14 %.
Tax expenses as a percentage of profits decreased slightly by -9.88 % compared to last year, with a more notable quarter-on-quarter decrease of -16.12 %. Net profit fell by -39.43 % year-on-year but experienced a 3.11 % expansion from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual downturn of -39.44 % but a quarterly rise of 3.09 %. In summary, Bayer CropScience Limited.’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.

Metrics Previous Year Previous Quarter Current Quarter Quarter to Quarter Difference Year to Year Difference
Sales Rs. 982.5 Cr Rs. 954.9 Cr Rs. 791.5 Cr -17.11 % -19.44 %
Expenses Rs. 776.7 Cr Rs. 827 Cr Rs. 694.9 Cr -15.97 % -10.53 %
Operating Profit Rs. 205.8 Cr Rs. 127.9 Cr Rs. 96.6 Cr -24.47 % -53.06 %
Net Profit Rs. 158.5 Cr Rs. 93.1 Cr Rs. 96 Cr + 3.11 % -39.43 %
EPS in Rs Rs. 35.27 Rs. 20.72 Rs. 21.36 + 3.09 % -39.44 %


In reviewing Bayer CropScience Limited.’s 2024(Q4) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales experienced a decrease of -19.44 % year-on-year, although there was a slight dip of -17.11 % from the previous quarter. Expenses decreased by -10.53 % compared to the previous year, with a decrease of -15.97 % quarter-on-quarter. Operating Profit dropped by -53.06 % annually, and saw a -24.47 % decrease from the last quarter.
Net Profit showed yearly decrease of -39.43 %, and experienced a 3.11 % increase from the previous quarter. Earnings Per Share (EPS) fell by -39.44 % annually, however rose by 3.09 % compared to the last quarter. In essence, while Bayer CropScience Limited. exhibits strong annual growth indicators, short-term improvements suggest the potential for recovery and the importance of strategic adjustments to counter market challenges effectively. That’s all for now in the financial sector.

[my_shortcode1 values=”Bayer CropScience “]

Related Post